Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis.

IF 3.6 2区医学 Q2 RHEUMATOLOGY

Journal of Rheumatology Pub Date : 2025-01-01 DOI:10.3899/jrheum.2023-1237

Sherry Rohekar, Jordi Pardo Pardo, Reza Mirza, Sibel Z Aydin, Louis Bessette, Nicolas Richard, Dianne Mosher, Tristan Boyd, Jon Chan, Lihi Eder, Laura Passalent, Elie Karam, Bindu Nair, Glen S Hazlewood, Shirley Tse, Dax Rumsey, Michel Zummer, Nigil Haroon, Robert Inman, Dafna D Gladman

{"title":"Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis.","authors":"Sherry Rohekar, Jordi Pardo Pardo, Reza Mirza, Sibel Z Aydin, Louis Bessette, Nicolas Richard, Dianne Mosher, Tristan Boyd, Jon Chan, Lihi Eder, Laura Passalent, Elie Karam, Bindu Nair, Glen S Hazlewood, Shirley Tse, Dax Rumsey, Michel Zummer, Nigil Haroon, Robert Inman, Dafna D Gladman","doi":"10.3899/jrheum.2023-1237","DOIUrl":null,"url":null,"abstract":"Objective: To provide a set of living treatment recommendations that will give contemporary guidance on the management of patients with axial spondyloarthritis (axSpA) in Canada.Methods: The Spondyloarthritis Research Consortium of Canada (SPARCC), in conjunction with the Canadian Rheumatology Association, organized a treatment recommendations panel composed of rheumatologists, researchers, allied health professionals, and a patient advocate. A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach was used, in which existing guidelines were adopted or adapted to a Canadian context. Recommendations were also placed in a health equity framework.Results: Fifty-six recommendations were made for patients with active axSpA, stable axSpA, active or stable axSpA, for comorbidities, and for assessment, screening, and imaging. Recommendations were also made for principles of management, disease monitoring, and ethical considerations.Conclusion: These living treatment recommendations will provide up-to-date guidance for the management of axSpA for Canadian practice. As part of the living model, they will be updated regularly as changes occur in the treatment landscape.","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":"10-22"},"PeriodicalIF":3.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3899/jrheum.2023-1237","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To provide a set of living treatment recommendations that will give contemporary guidance on the management of patients with axial spondyloarthritis (axSpA) in Canada.

Methods: The Spondyloarthritis Research Consortium of Canada (SPARCC), in conjunction with the Canadian Rheumatology Association, organized a treatment recommendations panel composed of rheumatologists, researchers, allied health professionals, and a patient advocate. A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach was used, in which existing guidelines were adopted or adapted to a Canadian context. Recommendations were also placed in a health equity framework.

Results: Fifty-six recommendations were made for patients with active axSpA, stable axSpA, active or stable axSpA, for comorbidities, and for assessment, screening, and imaging. Recommendations were also made for principles of management, disease monitoring, and ethical considerations.

Conclusion: These living treatment recommendations will provide up-to-date guidance for the management of axSpA for Canadian practice. As part of the living model, they will be updated regularly as changes occur in the treatment landscape.

查看原文本刊更多论文

加拿大风湿病学协会/加拿大脊柱关节炎研究联合会《轴性脊柱关节炎生活治疗建议》。

目的：为加拿大轴性脊柱关节炎（axSpA）患者的治疗提供现代指导：方法：加拿大脊柱关节炎研究联合会（SPARCC）与加拿大风湿病学协会（Canadian Rheumology Association）联合组织了一个治疗建议小组，该小组由风湿病学家、加拿大风湿病学协会（Canadian Rheumology Association）和加拿大脊柱关节炎研究联合会（SPARCC）组成：加拿大脊柱关节炎研究联合会（SPARCC）与加拿大风湿病学协会联合组织了一个治疗建议小组，成员包括风湿病学家、研究人员、专职医疗人员和一名患者权益倡导者。该小组采用了建议评估、发展和评价分级（GRADE）-ADOLOPMENT 方法，根据加拿大的具体情况采用或调整了现有的指南。此外，还将建议纳入健康公平框架：针对活动性轴索硬化症患者、稳定型轴索硬化症患者、活动性或稳定型轴索硬化症患者、合并症以及评估、筛查和成像提出了 56 项建议。此外，还就管理原则、疾病监测和伦理考虑提出了建议：这些活体治疗建议将为加拿大轴性SpA的治疗提供最新指导。作为活模式的一部分，这些建议将随着治疗领域的变化而定期更新。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Rheumatology 医学-风湿病学

CiteScore

6.50

自引率

5.10%

发文量

285

审稿时长

1 months

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.